Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection

References

• European Association for the Study of the Liver, Electronic address: [email protected], European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol, 2017;67(2):370–398.
   PubMed Web of Science ®Google Scholar
• Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599.
   PubMed Web of Science ®Google Scholar
• Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1–98.
   PubMed Web of Science ®Google Scholar
• Terrault NA, Bzowej NH, Chang K-M, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261–283.
   PubMed Web of Science ®Google Scholar
• Domingo E, Martín V, Perales C, et al. Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol. 2006;299:51–82.
   PubMed Web of Science ®Google Scholar
• Domingo E, Gomez J. Quasispecies and its impact on viral hepatitis. Virus Res. 2007;127(2):131–150.
   PubMed Web of Science ®Google Scholar
• Domingo E, Sheldon J, Perales C. Viral quasispecies evolution. Microbiol Mol Biol Rev. 2012;76(2):159–216.
   PubMed Web of Science ®Google Scholar
• Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog. 2010;6(7):e1001005.
   PubMed Web of Science ®Google Scholar
• Lim SG, Cheng Y, Guindon S, et al. Viral quasi-species evolution during hepatitis Be antigen seroconversion. Gastroenterology. 2007;133(3):951–958.
   Web of Science ®Google Scholar
• Chen L, Gan QR, Zhang DQ, et al. Increased intrahepatic quasispecies heterogeneity correlates with off-treatment sustained response to nucleos(t)ide analogues in e antigen-positive chronic hepatitis B patients. Clin Microbiol Infect. 2016;22(2):201–207.
   Web of Science ®Google Scholar
• Wagner J, Yuen L, Littlejohn M, et al. Analysis of Hepatitis B virus haplotype diversity detects striking sequence conservation across genotypes and chronic disease phase. Hepatology. 2020. doi:https://doi.org/10.1002/hep.31516. PMID: 32780526.
   Google Scholar
• Ayres A, Yuen L, Jackson KM, et al. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations. J Viral Hepat. 2014;21(11):809–817.
   PubMed Web of Science ®Google Scholar
• Bayliss J, Nguyen T, Lesmana C, et al. Advances in the molecular diagnosis of hepatitis B infection: providing insight into the next generation of disease. Semin Liver Dis. 2013;33(2):113–121.
   PubMed Web of Science ®Google Scholar
• Barzon L, Lavezzo E, Costanzi G, et al. Next-generation sequencing technologies in diagnostic virology. J Clin Virol. 2013;58(2):346–350.
   PubMed Web of Science ®Google Scholar
• Bayliss J, Yuen L, Rosenberg G, et al. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B. Gut. 2017;66(11):2013–2023.
   Web of Science ®Google Scholar
• Tseng TC, Liu C-J, Yang H-C, et al. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 2015;64(2):292–302.
   Web of Science ®Google Scholar
• Wang M, Li J, Zhang X, et al. An integrated software for virus community sequencing data analysis. BMC Genomics. 2020;21(1):363.
   Web of Science ®Google Scholar
• Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19(6):1513–1520.
   PubMed Web of Science ®Google Scholar
• Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317–1325.
   PubMed Web of Science ®Google Scholar
• Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–526.
   PubMed Web of Science ®Google Scholar
• Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathologie Biologie. 2010;58(4):258–266.
   PubMedGoogle Scholar
• Vanlandschoot P, Cao T, Leroux-Roels G. The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure. Antiviral Res. 2003;60(2):67–74.
   Web of Science ®Google Scholar
• Sede M, Lopez-Ledesma M, Frider B, et al. Hepatitis B virus depicts a high degree of conservation during the immune-tolerant phase in familiarly transmitted chronic hepatitis B infection: deep-sequencing and phylogenetic analysis. J Viral Hepat. 2014;21(9):650–661.
   Web of Science ®Google Scholar
• Kennedy PTF, Sandalova E, Jo J, et al. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology. 2012;143(3):637–645.
   PubMed Web of Science ®Google Scholar
• Mason WS, Gill US, Litwin S, et al. HBV DNA integration and clonal hepatocyte expansion in chronic Hepatitis B patients considered immune tolerant. Gastroenterology. 2016;151(5):986–998.e4.
   PubMed Web of Science ®Google Scholar
• Yuen L, Revill PA, Rosenberg G, et al. HBV variants are common in the ‘immune-tolerant’ phase of chronic hepatitis B. J Viral Hepat. 2020;27(10):1061–1070.
   Web of Science ®Google Scholar
• Yang L, Ma S, Hu X, et al. Presence of valine at position 27 of the hepatitis B virus core gene is associated with severe liver inflammation in Chinese patients. J Med Virol. 2011;83(2):218–224.
   Web of Science ®Google Scholar
• Ducancelle A, Pivert A, Bertrais S, et al. Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity. J Gastroenterol Hepatol. 2016;31(10):1750–1756.
   Web of Science ®Google Scholar
• Li F, Zhang D, Li Y, et al. Whole genome characterization of hepatitis B virus quasispecies with massively parallel pyrosequencing. Clin Microbiol Infect. 2015;21(3):280–287.
   Web of Science ®Google Scholar
• Zhu S, Zhang H, Dong Y, et al. Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: a pilot open-label randomized study. Journal of Hepatology. 2018;68(6):1123–1128.
   PubMed Web of Science ®Google Scholar
• Kumar M, Sarin SK, Hissar S, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology. 2008;134(5):1376–1384.
   PubMed Web of Science ®Google Scholar
• Lai M, Hyatt BJ, Nasser I, et al. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007;47(6):760–767.
   PubMed Web of Science ®Google Scholar
• Martinot-Peignoux M, Carvalho-Filho R, Lapalus M, et al. Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients. J Hepatol. 2013;58(6):1089–1095.
   PubMed Web of Science ®Google Scholar
• Afdhal NH, Bacon BR, Patel K, et al. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol Hepatol. 2015;13(4):772–779.e1-3.
   PubMed Web of Science ®Google Scholar
• Ettel MG, Appelman HD. Approach to the liver biopsy in the patient with chronic low-level aminotransferase elevations. Arch Pathol Lab Med. 2018;142(10):1186–1190.
   Web of Science ®Google Scholar
• Gao S, Li X-Y, Fan Y-C, et al. A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤2 upper limit of normal. J Gastroenterol Hepatol. 2017;32(1):215–220.
   Web of Science ®Google Scholar
• Chen J, Xu CR, Xi M, et al. Predictors of liver histological changes and a sustained virological response to peginterferon among chronic hepatitis B e antigen-positive patients with normal or minimally elevated alanine aminotransferase levels. J Viral Hepat. 2017;24(7):573–579.
   Web of Science ®Google Scholar
• Rodriguez-Frias F, Buti M, Tabernero D, et al. Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach. World J Gastroenterol. 2013;19(41):6995–7023.
   PubMed Web of Science ®Google Scholar
• McNaughton AL, D’Arienzo V, Ansari MA, et al. Insights from deep sequencing of the HBV genome-unique, tiny, and misunderstood. Gastroenterology. 2019;156(2):384–399.
   PubMed Web of Science ®Google Scholar
• Liu F, Chen L, Yu D-M, et al. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy. Gut. 2011;60(9):1269–1277.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang Q, Yu D-m, et al. Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy. J Hepatol. 2009;50(5):895–905.
   PubMed Web of Science ®Google Scholar
• Gregori J, Perales C, Rodriguez-Frias F, et al. Viral quasispecies complexity measures. Virology. 2016;493:227–237.
   PubMed Web of Science ®Google Scholar
• Sarangi AN, Goel A, Aggarwal R. Methods for studying gut microbiota: a primer for physicians. J Clin Exp Hepatol. 2019;9(1):62–73.
   PubMed Web of Science ®Google Scholar
• Porter TM, Hajibabaei M. Scaling up: a guide to high-throughput genomic approaches for biodiversity analysis. Mol Ecol. 2018;27(2):313–338.
   Web of Science ®Google Scholar
• Libbrecht MW, Noble WS. Machine learning applications in genetics and genomics. Nat Rev Genet. 2015;16(6):321–332.
   PubMed Web of Science ®Google Scholar